WSD0922-FU, WSD0922-FU
WS2202
Phase 2 small_molecule active
Quick answer
WSD0922-FU, WSD0922-FU for Non-Small Cell Lung Cancer is a Phase 2 program (small_molecule) at Pharm Research Associates (UK) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharm Research Associates (UK) Limited
- Indication
- Non-Small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active